AAAAAA

   
Results: 1-25 |
Results: 25
Decreased cyclin B1 expression contributes to G(2) delay in human brain tumor cells after treatment with camptothecin
Authors: Janss, AJ Maity, A Tang, CB Muschel, RJ McKenna, WG Sutton, L Phillips, PC
Citation: Aj. Janss et al., Decreased cyclin B1 expression contributes to G(2) delay in human brain tumor cells after treatment with camptothecin, NEURO-ONCOL, 3(1), 2001, pp. 11-21
Ras inhibitors and radiation therapy
Authors: Jones, HA Hahn, SM Bernhard, E McKenna, WG
Citation: Ha. Jones et al., Ras inhibitors and radiation therapy, SEM RAD ONC, 11(4), 2001, pp. 328-337
Detection of repair activity during the DNA damage-induced G2 delay in human cancer cells
Authors: Kao, GD McKenna, WG Yen, TJ
Citation: Gd. Kao et al., Detection of repair activity during the DNA damage-induced G2 delay in human cancer cells, ONCOGENE, 20(27), 2001, pp. 3486-3496
ICTR 2000: Individualizing cancer treatment
Authors: Bernier, J Bentzen, SM McKenna, WG McMillan, TJ Zelefsky, MJ
Citation: J. Bernier et al., ICTR 2000: Individualizing cancer treatment, INT J RAD O, 49(2), 2001, pp. 299-299
Hypoxia in human intraperitoneal and extremity sarcomas
Authors: Evans, SM Hahn, SM Magarelli, DP Zhang, PJ Jenkins, WT Fraker, DL Hsi, RA McKenna, WG Koch, CJ
Citation: Sm. Evans et al., Hypoxia in human intraperitoneal and extremity sarcomas, INT J RAD O, 49(2), 2001, pp. 587-596
Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitrolmidazoles
Authors: Koch, CJ Hahn, SM Rockwell, K Covey, JM McKenna, WG Evans, SM
Citation: Cj. Koch et al., Pharmacokinetics of EF5 [2-(2-nitro-1-H-imidazol-1-yl)-N-(2,2,3,3,3-pentafluoropropyl) acetamide] in human patients: implications for hypoxia measurements in vivo by 2-nitrolmidazoles, CANC CHEMOT, 48(3), 2001, pp. 177-187
Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia
Authors: Malkowicz, SB McKenna, WG Vaughn, DJ Wan, XS Propert, KJ Rockwell, K Marks, SHF Wein, AJ Kennedy, AR
Citation: Sb. Malkowicz et al., Effects of Bowman-Birk inhibitor concentrate (BBIC) in patients with benign prostatic hyperplasia, PROSTATE, 48(1), 2001, pp. 16-28
Farnesyltransferase inhibitors
Authors: Hahn, SM Bernhard, E McKenna, WG
Citation: Sm. Hahn et al., Farnesyltransferase inhibitors, SEMIN ONCOL, 28(5), 2001, pp. 86-93
Ras regulation of radioresistance in cell culture
Authors: Gupta, AK Bakanauskas, VJ McKenna, WG Bernhard, EJ Muschel, RJ
Citation: Ak. Gupta et al., Ras regulation of radioresistance in cell culture, METH ENZYM, 333, 2001, pp. 284-290
The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras
Authors: Cohen-Jonathan, E Evans, SM Koch, CJ Muschel, RJ McKenna, WG Wu, JM Bernhard, EJ
Citation: E. Cohen-jonathan et al., The farnesyltransferase inhibitor L744,832 reduces hypoxia in tumors expressing activated H-ras, CANCER RES, 61(5), 2001, pp. 2289-2293
The Ras radiation resistance pathway
Authors: Gupta, AK Bakanauskas, VJ Cerniglia, GJ Chen, Y Bernhard, EJ Muschel, RJ McKenna, WG
Citation: Ak. Gupta et al., The Ras radiation resistance pathway, CANCER RES, 61(10), 2001, pp. 4278-4282
Prenyltransferase inhibitors as radiosensitizers
Authors: Bernhard, EJ Muschel, RH Cohen-Jonathan, E Favre, G Hamilton, AD Sebti, SM McKenna, WG
Citation: Ej. Bernhard et al., Prenyltransferase inhibitors as radiosensitizers, CANC DRUG, 8, 2001, pp. 171-195
DNA as an important target in radiation-induced apoptosis of MYC and MTC plus RAS transfected rat embryo fibroblasts
Authors: Ayene, IS Bernhard, EJ McKenna, WG Muschel, RJ Krisch, RE Koch, CJ
Citation: Is. Ayene et al., DNA as an important target in radiation-induced apoptosis of MYC and MTC plus RAS transfected rat embryo fibroblasts, INT J RAD B, 76(3), 2000, pp. 343-354
Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer
Authors: Robnett, TJ Machtay, M Vines, EF McKenna, MG Algazy, KM McKenna, WG
Citation: Tj. Robnett et al., Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer, INT J RAD O, 48(1), 2000, pp. 89-94
Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS
Authors: Cohen-Jonathan, E Muschel, RJ McKenna, WG Evans, SM Cerniglia, G Mick, R Kusewitt, D Sebti, SM Hamilton, AD Oliff, A Kohl, N Gibbs, JB Bernhard, EJ
Citation: E. Cohen-jonathan et al., Farnesyltransferase inhibitors potentiate the antitumor effect of radiation on a human tumor xenograft expressing activated HRAS, RADIAT RES, 154(2), 2000, pp. 125-132
RAS-mediated radiation resistance is not linked to MAP kinase activation in two bladder carcinoma cell lines
Authors: Gupta, AK Bernhard, EJ Bakanauskas, VJ Wu, JM Muschel, RJ McKenna, WG
Citation: Ak. Gupta et al., RAS-mediated radiation resistance is not linked to MAP kinase activation in two bladder carcinoma cell lines, RADIAT RES, 154(1), 2000, pp. 64-72
Detection of hypoxia in human squamous cell carcinoma by EF5 binding
Authors: Evans, SM Hahn, S Pook, DR Jenkins, WT Chalian, AA Zhang, P Stevens, C Weber, R Weinstein, G Benjamin, I Mirza, N Morgan, M Rubin, S McKenna, WG Lord, EM Koch, CJ
Citation: Sm. Evans et al., Detection of hypoxia in human squamous cell carcinoma by EF5 binding, CANCER RES, 60(7), 2000, pp. 2018-2024
Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines
Authors: Bernhard, EJ Stanbridge, EJ Gupta, S Gupta, AK Soto, D Bakanauskas, VJ Cerniglia, GJ Muschel, RJ McKenna, WG
Citation: Ej. Bernhard et al., Direct evidence for the contribution of activated N-ras and K-ras oncogenes to increased intrinsic radiation resistance in human tumor cell lines, CANCER RES, 60(23), 2000, pp. 6597-6600
How does radiation kill cells?
Authors: Cohen-Jonathan, E Bernhard, EJ McKenna, WG
Citation: E. Cohen-jonathan et al., How does radiation kill cells?, CURR OP C B, 3(1), 1999, pp. 77-83
Radiosensitivity and the cell cycle
Authors: Bernhard, EJ McKenna, WG Muschel, RJ
Citation: Ej. Bernhard et al., Radiosensitivity and the cell cycle, CA J SCI AM, 5(4), 1999, pp. 194-204
Therapeutic resistance: characterization and inactivation by specific antiserum of a putative protein family produced by tumour cells
Authors: Zhou, S Li, W Hill, HZ Hill, GJ Kueppers, F McKenna, WG Muschel, RJ Wolansky, LJ Silva, HC
Citation: S. Zhou et al., Therapeutic resistance: characterization and inactivation by specific antiserum of a putative protein family produced by tumour cells, MELANOMA RE, 9(1), 1999, pp. 40-50
A novel chemotherapeutic regimen (interferon alfa, zidovudine, and etretinate) for adult T-cell lymphoma resulting in rapid tumor destruction
Authors: Chan, EE Dowdy, YG Lee, B McKenna, WG Fox, KR Levy, RJ Wasik, MA Rook, AH
Citation: Ee. Chan et al., A novel chemotherapeutic regimen (interferon alfa, zidovudine, and etretinate) for adult T-cell lymphoma resulting in rapid tumor destruction, J AM ACAD D, 40(1), 1999, pp. 116-121
Non-small cell lung cancer: Prognostic factors in patients treated with surgery and postoperative radiation therapy
Authors: Lee, JH Machtay, M Kaiser, LR Friedberg, JS Hahn, SM McKenna, MG McKenna, WG
Citation: Jh. Lee et al., Non-small cell lung cancer: Prognostic factors in patients treated with surgery and postoperative radiation therapy, RADIOLOGY, 213(3), 1999, pp. 845-852
P34(Cdc2) kinase activity is excluded from the nucleus during the radiation-induced G(2) arrest in HeLa cells
Authors: Kao, GD McKenna, WG Muschel, RJ
Citation: Gd. Kao et al., P34(Cdc2) kinase activity is excluded from the nucleus during the radiation-induced G(2) arrest in HeLa cells, J BIOL CHEM, 274(49), 1999, pp. 34779-34784
Radiosensitization and apoptosis
Authors: Muschel, RJ Soto, DE McKenna, WG Bernhard, EJ
Citation: Rj. Muschel et al., Radiosensitization and apoptosis, ONCOGENE, 17(25), 1998, pp. 3359-3363
Risultati: 1-25 |